Endometrial Cancer Trial, Recruiting NCT06815939 Sponsor: DL Analytics Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06815939
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 30 and 59 years of age

Who may not be able to join:

  • Women who are pregnant at the time of the colposcopy or biopsy procedure
  • Women who have had a hysterectomy where the cervix was also removed
  • Women who have had an HPV test at any point in the last 5 years, whether the result was positive or negative
  • Women who have been diagnosed with or treated for cervical cancer in the last 5 years
  • Women who are unwilling or unable to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Karla Alfaro, MD, Basic Health International, Inc.

Phone: 817-966-5600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
DL Analytics
Registry
ClinicalTrials.gov
Start date
12 February 2025
Est. completion
31 July 2026

Where this trial is recruiting

El Salvador

Primary endpoints

Sensitivity; Positive Predictive Value (PPV)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov